Annovis Bio (07X) Q3 2024 Earnings Report
DE:07X Q3 2024 EPS Results
- Actual EPS
- -EUR 0.84
- Consensus EPS
- -EUR 0.59
- Beat/Miss
- Missed by -EUR 0.25
- One Year Ago EPS
- -EUR 1.41
DE:07X Q3 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 11/11/2024
- Time
- Before Open
- Conference Call
- Monday, November 11, 2024
DE:07X Upcoming Earnings
Annovis Bio's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q3 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:07X Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q3) | -0.26- | -0.32 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | -0.39-0.35 | -0.28 | -25.00% (-0.07) | |
| May 15, 2026 | 2026 (Q1) | -0.34-0.54 | -0.28 | -96.88% (-0.27) | |
| Mar 16, 2026 | 2025 (Q4) | -0.27-0.34 | -0.37 | 9.30% (+0.03) | |
| Nov 12, 2025 | 2025 (Q3) | -0.33-0.32 | -0.84 | 61.86% (+0.52) | |
| Aug 12, 2025 | 2025 (Q2) | -0.35-0.28 | -0.38 | 27.27% (+0.10) | |
| May 13, 2025 | 2024 (Q4) | -0.35-0.28 | -0.62 | 55.56% (+0.35) | |
| Nov 11, 2024 | 2024 (Q3) | -0.59-0.84 | -1.41 | 40.49% (+0.57) | |
| Aug 15, 2024 | 2024 (Q2) | -0.54-0.38 | -0.92 | 58.88% (+0.54) | |
| May 13, 2024 | 2024 (Q1) | ―- | -1.03 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
